Infection Analysis and Control Strategy of Intravenous Drug Config-uration Central Hospital
Abstract
Purpose: Conducting analysis mainly on the infection situation of intravenous drug configuration central hospital and take appropriate infection control strategies in order to reduce its infection rates. Method: 300 cases of transfusion patients were randomly divided into experimental and control group of 150 cases respectively. Experimental group of patients took systemic infection prevention and control measures, while control group of patients took merely the traditional nursing intervention. Comparative analysis of infection factors and rate of incidence were conducted on both groups of patients. Results: the main causes of infection in the drug configuration central hospital were operator personnel and storage of drugs etc.. Infection rate of the experimental group was lower than that of the control group, which the difference was statistically significant (P < 0.05). Conclusion: Strengthening attention towards the relevant factors in order to achieve minimum incidence of infections in the hospital.References
2. Li Zhen, Wang Ming Li, Su Li. Factors analysis of intravenous drug formulations central hospital infections [J]. Chinese Journal of Hospital Infection, 2014,16:4136-4137+4142.
3. Luo Cai Hong. Analysis of intravenous drug configuration center in strengthening hospital infection management [J]. Chinese Medicine Guide, 2013,04:673-674.
4. Chen Hong Yan, Liu Si Yuan, Liu Li, Liao Hong, Li Shi. Practice and experience of our hospital on intravenous drug configuration center establishment. Chinese Medicine,2011,02:53-54.
5. Fu Meng Li. Effect analysis of intravenous drug configuration central established by hospital. China Continuing Medical Education, 2015,23:16-17.
6. Ye Qi Wang, Shen Hong Wei, Liang Xiao Mei. Methods of intravenous drug configuration central in strengthening hospital infection management [J]. Journal of Chinese Medicine, 2015,20:87-88
Copyright (c) 2016 He Fu, Li Zhigang, Zhu Hui
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.